Home › Companies › 10X GENOMICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and 10X GENOMICS INC.’s Form 8-K, filed June 5, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of June 3, 2025: 4 items on 10X GENOMICS INC.’s Form 8-K, filed June 5, 2025: 2 approved · 2 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore 10X GENOMICS INC. in the interactive database Compare manager voting policies
These tallies are 10X GENOMICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 5, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Sri Kosaraju | 189,313,724 | 7,243,542 | 172,526 | -- | 19,837,766 | 96% | Not verified | — |
| Elect Director: Shehnaaz Suliman | 168,973,468 | 27,595,026 | 161,298 | -- | 19,837,766 | 86% | Not verified | — |
| 2. Ratification of Independent Registered Public Accounting Firm | 215,766,816 | 312,396 | 488,346 | -- | -- | 99.8% | Approved | — |
| 3. Non-binding, Advisory Vote to Approve Executive Compensation of Named Executive Officers | 164,321,765 | 32,192,042 | 215,985 | -- | 19,837,766 | 84% | Approved | — |
Source: 10X GENOMICS INC., Form 8-K, filed with the SEC on June 5, 2025 — read the filing on EDGAR.
Each item below shows how the 277 asset managers that disclosed a 10X GENOMICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 5 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
Description as filed by funds: Election of the Class III directors, each to serve a three-year term expiring at the 2028 annual meeting of stockholders or until such director's successors are duly elected and qualified or until such director's earlier death, resignation, disqualification or removal: Shehnaaz Suliman
10X GENOMICS INC.’s own tally for this item (“Elect Director: Shehnaaz Suliman”): 168,973,468 for, 27,595,026 against, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 86% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 59 asset managers below reported 37,993,917 for, 3,482,903 against, 5,725 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 10,468,494 | 1,745,533 | 0 | 0 | Mixed |
| ARK ETF Trust | 11,685,143 | 0 | 0 | 0 | For |
| Vanguard | 11,146,941 | 921 | 0 | 0 | For |
| BlackRock | 2,235,570 | 0 | 0 | 0 | For |
| Capital Group | 1,452,300 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 652,941 | 0 | 0 | Against |
| AMERICAN BEACON FUNDS | 256,431 | 0 | 0 | 0 | For |
| TIAA | 0 | 193,983 | 0 | 0 | Against |
| Columbia Threadneedle | 128,546 | 0 | 0 | 0 | For |
| Global X | 0 | 123,044 | 0 | 0 | Against |
| Exchange Place Advisors Trust | 0 | 120,562 | 0 | 0 | Against |
| ARK Venture Fund | 96,720 | 0 | 0 | 0 | For |
| Voya | 0 | 95,424 | 0 | 0 | Against |
| Morgan Stanley | 82,018 | 0 | 0 | 0 | For |
| Equitable | 55,370 | 26,354 | 0 | 0 | Mixed |
| Pacific Life | 81,614 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST III | 78,523 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 77,014 | 0 | 0 | 0 | For |
| Lincoln Financial | 3,416 | 63,860 | 0 | 0 | Mixed |
| Nationwide | 0 | 55,973 | 0 | 0 | Against |
| SEI | 0 | 50,514 | 0 | 0 | Against |
| Invesco | 0 | 50,328 | 0 | 0 | Against |
| PACE SELECT ADVISORS TRUST | 0 | 46,308 | 0 | 0 | Against |
| T. Rowe Price | 46,201 | 0 | 0 | 0 | For |
| ALGER FUNDS | 0 | 38,365 | 0 | 0 | Against |
Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of the Class III directors, each to serve a three-year term expiring at the 2028 annual meeting of stockholders or until such director's successors are duly elected and qualified or until such director's earlier death, resignation, disqualification or removal: Sri Kosaraju
10X GENOMICS INC.’s own tally for this item (“Elect Director: Sri Kosaraju”): 189,313,724 for, 7,243,542 against, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 59 asset managers below reported 41,311,794 for, 165,026 against, 5,725 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,214,027 | 0 | 0 | 0 | For |
| ARK ETF Trust | 11,685,143 | 0 | 0 | 0 | For |
| Vanguard | 11,146,942 | 920 | 0 | 0 | For |
| BlackRock | 2,235,570 | 0 | 0 | 0 | For |
| Capital Group | 1,452,300 | 0 | 0 | 0 | For |
| Charles Schwab | 652,941 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 256,431 | 0 | 0 | 0 | For |
| TIAA | 193,983 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 128,546 | 0 | 0 | 0 | For |
| Global X | 123,044 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 120,562 | 0 | 0 | 0 | For |
| ARK Venture Fund | 96,720 | 0 | 0 | 0 | For |
| Voya | 0 | 95,424 | 0 | 0 | Against |
| Morgan Stanley | 82,018 | 0 | 0 | 0 | For |
| Equitable | 55,370 | 26,354 | 0 | 0 | Mixed |
| Pacific Life | 81,614 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST III | 78,523 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 77,014 | 0 | 0 | 0 | For |
| Lincoln Financial | 64,105 | 3,171 | 0 | 0 | For |
| Nationwide | 55,973 | 0 | 0 | 0 | For |
| SEI | 50,514 | 0 | 0 | 0 | For |
| Invesco | 50,328 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 46,308 | 0 | 0 | 0 | For |
| T. Rowe Price | 46,201 | 0 | 0 | 0 | For |
| ALGER FUNDS | 38,365 | 0 | 0 | 0 | For |
Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.
Combines 13 wordings of this item as funds reported it.
84% Approved · of votes cast
Description as filed by funds: To approve, on a non-binding, advisory basis, the compensation of our named executive officers.
10X GENOMICS INC.’s own tally for this item (“3. Non-binding, Advisory Vote to Approve Executive Compensation of Named Executive Officers”): 164,321,765 for, 32,192,042 against — passed, per its Form 8-K filed June 5, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 - Non-binding, Advisory Vote to Approve Executive Compensation of Named Executive Officers The Company's stockholders approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers as described in more detail in the Company's definitive proxy state…”
Support: 84% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,160,391 | 53,636 | 0 | 0 | For |
| ARK ETF Trust | 11,685,143 | 0 | 0 | 0 | For |
| Vanguard | 11,146,941 | 921 | 0 | 0 | For |
| BlackRock | 158,880 | 2,076,690 | 0 | 0 | Mixed |
| Capital Group | 0 | 1,452,300 | 0 | 0 | Against |
| Charles Schwab | 0 | 652,941 | 0 | 0 | Against |
| AMERICAN BEACON FUNDS | 256,431 | 0 | 0 | 0 | For |
| TIAA | 0 | 193,983 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 128,546 | 0 | 0 | Against |
| Global X | 0 | 123,044 | 0 | 0 | Against |
| Exchange Place Advisors Trust | 0 | 120,562 | 0 | 0 | Against |
| ARK Venture Fund | 96,720 | 0 | 0 | 0 | For |
| Voya | 0 | 95,424 | 0 | 0 | Against |
| Morgan Stanley | 0 | 82,018 | 0 | 0 | Against |
| Equitable | 0 | 81,724 | 0 | 0 | Against |
| Pacific Life | 75,770 | 5,844 | 0 | 0 | Mixed |
| NORTHERN LIGHTS FUND TRUST III | 0 | 78,523 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 15,828 | 61,186 | 0 | 0 | Mixed |
| Lincoln Financial | 0 | 67,276 | 0 | 0 | Against |
| Nationwide | 0 | 55,973 | 0 | 0 | Against |
| SEI | 0 | 50,514 | 0 | 0 | Against |
| Invesco | 0 | 50,328 | 0 | 0 | Against |
| PACE SELECT ADVISORS TRUST | 0 | 46,308 | 0 | 0 | Against |
| T. Rowe Price | 0 | 46,201 | 0 | 0 | Against |
| ALGER FUNDS | 0 | 38,365 | 0 | 0 | Against |
Fund voting reports, all 59 managers: 35,663,218 for, 5,813,602 against, 5,725 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 10,761,308 | 0 | 0 | 0 | For |
| Nikko Asset Management Co., Ltd. | 0 | 5,389,611 | 0 | 0 | Against |
| BlackRock | 525,594 | 2,134,291 | 0 | 0 | Mixed |
| Two Sigma | 0 | 2,159,053 | 0 | 0 | Against |
| UBS | 0 | 2,111,528 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 1,962,561 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 0 | 1,655,103 | 0 | 0 | Against |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1,505,585 | 0 | 0 | 0 | For |
| Capital Group | 0 | 1,452,300 | 0 | 0 | Against |
| State Street | 1,401,972 | 47,580 | 0 | 0 | For |
| Camber Capital Management LP | 0 | 1,000,000 | 0 | 0 | Against |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0 | 751,273 | 0 | 0 | Against |
| Charles Schwab | 0 | 653,315 | 0 | 0 | Against |
| AQR | 0 | 601,164 | 0 | 0 | Against |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0 | 525,945 | 0 | 0 | Against |
| Sands Capital Alternatives, LLC | 0 | 481,770 | 0 | 0 | Against |
| BOSTON MANAGEMENT & RESEARCH | 0 | 467,079 | 0 | 0 | Against |
| MARSHALL WACE, LLP | 0 | 439,403 | 0 | 0 | Against |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 0 | 399,413 | 0 | 0 | Against |
| ARK Investment Management LLC | 356,669 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 325,693 | 0 | 0 | Against |
| Amundi | 0 | 320,340 | 0 | 0 | Against |
| Northern Trust | 278,556 | 10,852 | 0 | 0 | For |
| Vestmark Advisory Solutions, Inc. | 0 | 285,137 | 0 | 0 | Against |
| Morgan Stanley | 0 | 274,764 | 0 | 0 | Against |
Institutional-manager reports, all 236 managers: 17,660,844 for, 25,638,771 against, 84,291 abstained, 50,939 not voted. Showing the 25 largest; see all in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.8% Approved · of votes cast
Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025; and
10X GENOMICS INC.’s own tally for this item (“2. Ratification of Independent Registered Public Accounting Firm”): 215,766,816 for, 312,396 against — passed, per its Form 8-K filed June 5, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 - Ratification of Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2025.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 59 asset managers below reported 41,397,442 for, 79,378 against, 5,725 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,214,027 | 0 | 0 | 0 | For |
| ARK ETF Trust | 11,685,143 | 0 | 0 | 0 | For |
| Vanguard | 11,147,862 | 0 | 0 | 0 | For |
| BlackRock | 2,235,570 | 0 | 0 | 0 | For |
| Capital Group | 1,452,300 | 0 | 0 | 0 | For |
| Charles Schwab | 652,941 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 256,431 | 0 | 0 | 0 | For |
| TIAA | 193,983 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 128,546 | 0 | 0 | 0 | For |
| Global X | 123,044 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 120,562 | 0 | 0 | 0 | For |
| ARK Venture Fund | 96,720 | 0 | 0 | 0 | For |
| Voya | 95,424 | 0 | 0 | 0 | For |
| Morgan Stanley | 82,018 | 0 | 0 | 0 | For |
| Equitable | 81,724 | 0 | 0 | 0 | For |
| Pacific Life | 81,614 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST III | 0 | 78,523 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 77,014 | 0 | 0 | 0 | For |
| Lincoln Financial | 67,276 | 0 | 0 | 0 | For |
| Nationwide | 55,973 | 0 | 0 | 0 | For |
| SEI | 50,514 | 0 | 0 | 0 | For |
| Invesco | 50,328 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 46,308 | 0 | 0 | 0 | For |
| T. Rowe Price | 46,201 | 0 | 0 | 0 | For |
| ALGER FUNDS | 38,365 | 0 | 0 | 0 | For |
Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.
Not shown here: this season’s fund filings also report 1 item from the meeting of June 11, 2024, which belongs to the 2023-2024 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 122,291,837 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 9.99% |
| 2 | ARK ETF Trust | 9.56% |
| 3 | Vanguard | 9.12% |
| 4 | BlackRock | 1.83% |
| 5 | Capital Group | 1.19% |
| 6 | Charles Schwab | 0.53% |
| 7 | AMERICAN BEACON FUNDS | 0.21% |
| 8 | TIAA | 0.16% |
| 9 | Columbia Threadneedle | 0.11% |
| 10 | Global X | 0.10% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 8.80% |
| 2 | Nikko Asset Management Co., Ltd. | 4.41% |
| 3 | BlackRock | 2.18% |
| 4 | Two Sigma | 1.77% |
| 5 | UBS | 1.73% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 1.60% |
| 7 | RA CAPITAL MANAGEMENT, L.P. | 1.35% |
| 8 | DEERFIELD MANAGEMENT COMPANY, L.P. | 1.23% |
| 9 | Capital Group | 1.19% |
| 10 | State Street | 1.19% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| ARK Investment Management LLC | 9.72% | 13G |
| Vanguard Group | 9.09% | 13F |
| FMR (Fidelity) | 8.09% | 13F |
| Vanguard Portfolio Management | 5.71% | 13G |
| BlackRock | 5.45% | 13F |
| Nikko Asset Management Americas, Inc. | 4.91% | 13G |
| Sumitomo Mitsui Trust Group, Inc. | 4.40% | 13G |
| Millennium Management | 4.40% | 13F |
| Amova Asset Management Americas, Inc. | 4.40% | 13G |
| Morgan Stanley | 2.27% | 13F |
Percentages above are of 122,291,837 shares outstanding, as reported by 10X GENOMICS INC. on its Form 10-K dated December 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from 10X GENOMICS INC.’s 10-K dated December 31, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At 10X GENOMICS INC.'s shareholder meeting held June 3, 2025, in the 2024-2025 proxy season, 277 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 1,179 separate fund positions. On the most widely held item on that ballot — To approve, on a non-binding, advisory basis, the compensation of our named executive officers. — 10X GENOMICS INC.'s filing reports the proposal as approved, with 84% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: 10X GENOMICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 5, 2025.
10X GENOMICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.